000
| 01227nam 2200301zi 4500 |
---|
001 | 9.923772 |
---|
003 | CaOODSP |
---|
005 | 20240221143052 |
---|
006 | m o d f |
---|
007 | cr |n||||||||| |
---|
008 | 230612t20242024onc o f|0| 0 eng d |
---|
020 | |a9780660491042 |
---|
040 | |aCaOODSP|beng|erda|cCaOODSP |
---|
043 | |an-cn--- |
---|
086 | 1 |aH164-352/2024E-PDF |
---|
245 | 00|aPost-notice of compliance (NOC) changes : |bguidance for quality of veterinary drugs. |
---|
264 | 1|a[Ottawa] : |bHealth Canada = Santé Canada, |c2024. |
---|
264 | 4|c©2024 |
---|
300 | |a1 online resource (iv, 63 pages) |
---|
336 | |atext|btxt|2rdacontent |
---|
337 | |acomputer|bc|2rdamedia |
---|
338 | |aonline resource|bcr|2rdacarrier |
---|
500 | |aIssued also in French under title: Changements survenus après l’avis de conformité [AC] : lignes directrices sur la qualité des médicaments vétérinaires. |
---|
650 | 0|aDrug approval|zCanada. |
---|
650 | 0|aVeterinary drugs|zCanada. |
---|
710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
---|
775 | 08|tChangements survenus après l’avis de conformité [AC] : |w(CaOODSP)9.923773 |
---|
856 | 40|qPDF|s1.42 MB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H164-352-2024-eng.pdf |
---|